Update: Virtual sessions will launch November 21, 2020
Following careful consideration, the American Headache Society (AHS) leadership has made the difficult yet necessary decision to cancel the in-person portion of the AHS Scottsdale Headache Symposium® originally scheduled for November 19 – 22, 2020, in Scottsdale, AZ. The meeting will now be a virtual event launching November 21, 2020. Please save the date and view our FAQ page for additional details.
The Scottsdale Headache Symposium® is designed for general practitioners, internists, pediatricians, neurologists, anesthesiologists, dentists, physical therapists, psychologists, psychiatrists, nurse practitioners, physician assistants, nurses, and other health professionals who treat headache. The Symposium provides practical, clinical, evidence-based information on the diagnosis, management and treatment of headache patients.
Registered attendees can access the meeting here.
Scottsdale Program Committee
Co-Chairs
| Deborah I. Friedman, MD, MPH, FAHS UT Southwestern Medical Center Dallas, Texas |
Stewart J. Tepper, MD, FAHS Geisel School of Medicine at Dartmouth Lebanon, New Hampshire |
| Christine Lay, MD, FAHS University of Toronto Toronto, Ontario |
Committee Members
| Jessica Ailani, MD, FAHS Medstar Georgetown University Hospital Washington, District of Columbia |
Rashmi B. Halker Singh, MD, FAHS Mayo Clinic Arizona Phoenix, Arizona |
| Andrew C. Charles, MD, FAHS David Geffen School of Medicine at UCLA Los Angeles, California |
Stephanie J. Nahas, MD, MSEd, FAHS Thomas Jefferson University Philadelphia, Pennsylvania |
| Carrie Dougherty, MD, FAHS Georgetown Headache Center Washington, District of Columbia |
Matthew S. Robbins, MD, FAHS Weill Cornell Medicine New York, New York |
| A. Laine Green, MD, FAHS Dalhousie University Halifax, Nova Scotia |
EDUCATIONAL OBJECTIVES
At the conclusion of this meeting, attendees should be better able to:
- Acquire basic knowledge in diagnosis, epidemiology, and treatment of primary and secondary headache disorders, to apply in clinical practice and research
- Clarify differences in the clinical characteristics of migraine, trigeminal autonomic cephalalgias, other primary and secondary headaches to optimize outcomes in clinical practice and research
- Extend their information base on the most important new cutting-edge Headache Medicine treatments for both utilization in and assessment of success in clinical practice
- Prepare options for practical application in the treatment of difficult to treat or refractory headaches
EDUCATION MISSION STATEMENT
The provision of quality CME is a primary mission of the American Headache Society®. The Society’s educational objectives are to continue to improve the knowledge, skills, and professional performance of physicians, psychologists, and other health professionals in the care of patients with head, neck, and orofacial pain by:
- Providing a forum for presentation of free scientific communication on research and clinical practice
- Providing educational symposia
- Improving education in medical schools and residency programs
- Identifying and developing new educational initiatives
- Supporting educational programs directed to people with head, neck, and orofacial pain
- Maintaining strict adherence to ACCME guidelines
- Developing education activities and tools that are designed and then evaluated for their role in improving the learners’ competence, performance, and the overall quality and safety of the care they give to individuals suffering from head, neck, and orofacial pain
CONTINUING MEDICAL EDUCATION
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Headache Society® designates this Other Activity (live and recorded) for a maximum of 29.50* AMA PRA Category 1 credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*Subject to change.
AAFP
The AAFP has reviewed 2020 American Headache Society Virtual Scottsdale Headache Symposium and deemed it acceptable for up to 25.50 Online Only, Live AAFP Prescribed credit. Term of Approval is from 11/21/2020 to 5/21/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE STATEMENT
All contributors who can affect American Headache Society CME content (including Leadership, Program Chairs, Program Committee Members, Moderators, Faculty, Speakers, Reviewers, Teachers, Authors, Medical Writers and Staff), in their respective roles, are required to disclose all relevant financial relationships with any commercial interest that could be viewed as a real or perceived conflict of interest. Contributors will also identify relevant financial relationships of their spouse, partner or immediate family. This policy is in effect to maintain adherence with the conflict of interest guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and the American Headache Society Ethics Committee.
Prior to the program, attendees will be made aware of the presence or absence of relevant financial relationships for any contributors who may affect the development, management, presentation or evaluation of the CME activity. The presence or absence of relevant financial relationships for any contributor who affects content are listed on the AHS website, mobile app (where applicable), presented verbally and in slide form. Individuals who refuse to disclose relevant financial relationships will be disqualified from being a contributor and cannot have control of, or responsibility for, the development, management presentation or evaluation of the CME activity.
Please click here to view financial disclosure information for this activity.
COMMERCIAL SUPPORT DISCLOSURE
AHS gratefully acknowledges the educational support of the Virtual Scottsdale Headache Symposium from our industry supporters:
Allergan, an AbbVie company (NYSE: ABBV)
Amgen, Inc.
AHS gratefully acknowledges the educational support of the Anatomy of Headache and Orofacial Pain: An Interventional Based Cadaver Course from our industry supporters:
Allergan, an AbbVie company (NYSE: ABBV)
2020 Virtual Scottsdale Headache Symposium Program Agenda*
*Subject to change
Click here to download a copy of the program agenda including Live-streamed Events, On Demand Presentations and Headache Lounges.
| Launch date: Saturday, November 21, 2020 9:00 AM PST |
| Live-streamed Events |
| 9:00am – 9:07am PST
Opening Remarks Peter J. Goadsby, MD, PhD, FAHS |
| 9:07am PST
Plenary I: What’s New in Diagnosis, Pathophysiology and Treatment |
| 9:07am – 9:22am PST
Diagnostic Pearls and Pitfalls |
| 9:22am – 9:40am PST
Migraine Epidemiology |
| 9:40am – 9:54am PST
Applied Migraine Pathophysiology |
| 9:54am – 10:09am PST
Acute Migraine Treatment |
| 10:09am – 10:23am PST
Migraine Preventive Treatment |
| 10:24am – 10:40am PST
Live Q&A with Presenters |
| 10:55am PST
Plenary II: Advanced Headache |
| 10:55am – 11:10am PST
Chronic Migraine |
| 11:10am – 11:24am PST
Cluster Headache |
| 11:24am – 11:55 am PST
Images in Headache: Test Your Knowledge |
| 11:56am – 12:11pm PST
Live Q&A with Presenters |
| 12:21pm PST
Plenary IV: Vascular Controversies in Migraine |
| 12:21pm – 12:31pm PST
Should I Prescribe these New Therapies to my Patient? |
| 12:31pm – 12:42pm PST
Is my Patient with Migraine at Risk for Stroke? |
| 12:42pm – 12:58pm PST
Does my Patient have a Primary Headache or a Vascular Secondary Headache? |
| 12:58pm – 1:13pm PST
Can my Patient with Migraine use Hormonal Therapies? |
| 1:13pm – 1:21pm PST
Triptans and Vascular Disease – Are my Fears Justified? |
| 1:21pm – 1:36pm PST
Live Q&A with Presenters |
| 1:45pm PST
Board of Directors Town Hall* *Separate registration is required. Register here. |
| On Demand Presentations |
| The Anatomy of Headache and Orofacial Pain: An Interventional Based Cadaver Course |
| Temporomandibular Disorders: Diagnosis and Management Marcelo Romero Reyes, DDS, PhD, FAHS |
| Cranial Neuralgias: Nerve Blocks and Other Interventional Procedures Paul G. Mathew, MD, FAHS |
| Cadaver Dissection Session Natalie R. Langley, PhD, D-ABFA |
| Headache Cooperative of the Pacific (HCOP) |
| Neuro-opthalmology and Headache Benjamin Frishberg, MD |
| Letters from the List Serv Susan L. Hutchinson, MD |
| Moving the Needle Andrew C. Charles, MD, FAHS |
| Patient Advocacy and the Role of the NP in Managing Headache Patients Annika Ehrlich, NP |
| SECTION SYMPOSIUM |
| Top Medical Cannabis Questions Posed to Headache Providers: Cautioning Your Patients with the Evidence |
| Medical Cannabis Mechanism of Action Niushen Zhang, MD |
| Evidence Review of Medical Cannabis for Headache Disorders Eric P. Baron, DO |
| A Review of the Current Epidemiology of Cannabis and Cannabinoid Use, Various Formulations and Strains Available and General Use Recommendations Eric P. Baron, DO |
| Highlighting the Potential Harm of Medical Cannabis Use with Patients Emmanuelle Schindler, MD, PhD |
| Educating on Headache: Expand Your Reach to Health Care Providers and Academic |
| The Adult Brain on Learning: Core Evidence Around How Adults Learn Anna Pace, MD |
| Making Your Research Shine: How to Effectively Write a Manuscript and Disseminate Scientific Knowledge Jason Roberts, PhD & Serena Orr, MD |
| Teaching Headache for the Clinician Educator Matthew S. Robbins, MD, FAHS |
| How to Effectively Educate the Scientific Community Elizabeth W. Loder, MD, MPH, FAHS |
| Career Development Course |
| Self Development & Self Promotion Jessica Ailani, MD, FAHS |
| Media Training & Tips Cynthia Armand, MD |
| Presentation Skills 101: Insider Secrets for Giving a Better Talk Scott Litin, MD |
| Diversifying the Field of Headache Medicine Larry (LC) Charleston, MD |
| Hospital Treatment of Refractory Migraine |
| Stratified Acute Tx to Reduce ED Presentations Mia Minen, MD, MPH, FAHS |
| Overview of Inpatient HA Treatment – Background, History, Options, and Patient Selection Morris Levin, MD, FAHS |
| Pharmacological Approaches for Repetitive Inpatient Infusion Treatment and Interventional Pain Options Inpatient Jennifer Robblee, MD |
| Inpatient Behavioral and Other Psychophysiological Options Steven M. Baskin, PhD |
| Headache 101 |
| Diagnostic Pearls Noah Rosen, MD, FAHS |
| Pathophysiology Todd J. Schwedt, MD, MSCI, FAHS |
| Acute Treatment Jennifer Robblee, BSc, MSc, MD, FRCPC |
| Prevention of Chronic Migraine Jack D. Schim, MD, FAHS |
| TACs Claire Sandoe, MD, MSc |
| Pediatrics Ana Marissa Lagman-Bartolome, MD |
| Behavioral Steve M. Baskin, PhD |
| Advanced Course: Neuroinflammation and Migraine |
| Overview of Neuroinflammation Andrew Russo, PhD |
| Inflammatory Priming of Dura Gregory Dussor, PhD |
| Sex and Stress on Meningeal Immune Cells Michael S. Gold, PhD |
| Treg Cells in Headache Yu-Qing Cao, PhD |
| CSD Activation of Meningeal Immune Cells Aaron Schain, PhD |
| Dural Mast Cells Dan Levy, PhD, MSc |
| NP / PA – The Bridge |
| Diagnosis Melissa Darsey, PA-C |
| Risk Factors Karen Williams, FNP-BC |
| Pathophysiology Maureen Moriarty, DNP, APRN, FAHS |
| Acute Medications Annika Ehrlich, NP |
| Prevention Laurel Short, FNP-C |
| Plenary III: Steven B. Graff-Radford Award Lectureship |
| Head, Tooth or Heart Ache? Tara Renton, BDS, MDSc, PhD |
| The Answer Is….. Jessica Ailani, MD, FAHS Peter J. Goadsby, MD, PhD, FAHS Lawrence C. Newman, MD, FAHS Stephen D. Silberstein, MD, FAHS Marcy E. Yonker, MD, FAHS |
| Plenary V: Cutting Edge / Emerging Therapies |
| Anti-CGRP Therapies David W. Dodick, MD, FAHS |
| Beyond CGRP: New and Emerging Therapies Michael J. Marmura, MD, FAHS |
| Neuromodulation Stewart J. Tepper, MD, FAHS |
| Frontiers in Headache Research Award Platform Presentations
Mindfulness-Based Cognitive Therapy and Self-Efficacy in People with Migraine Development and Characterization of Light-triggered Sleep Deprivation Preclinical Migraine Model in Females and Males Bridging the Knowledge Gap between Headache Medicine and Primary Care: The Development of a Case-based Headache Medicine Curriculum in a Primary Care Internal Medicine |
| Frontiers in Headache Research Award Poster Presentations
Dots and Spots: What do White Matter Lesions Mean? Real World Efficacy, Tolerability, and Safety Study of Lasmiditan – A Retrospective Study Double-blind Placebo-controlled Randomized Clinical Trial of Ginger (Zingiber officinale Rosc.) in the Acute and Prophylactic Treatment of Migraine Calcitonin Gene-related Peptide Monoclonal Antibody Wear-off Phenomenon in the Treatment of Migraine Did the Introduction of Calcitonin Gene-Related Peptide Monoclonal Antibodies Lead to Economic Changes for Patients? Improving Access to Migraine Care in Safety-net Populations with Alternative Methods of Clinical Care During the COVID-19 Pandemic A Retrospective Review to Evaluate the Efficacy of Occipital Nerve Blocks in the Treatment of Migraine During Pregnancy |
| Plenary VI: Women’s Health |
| Women’s Health Science Award Lecture
Women in Headache Medicine |
| Pregnancy Post-Partum / Conception Rebecca Burch, MD, FAHS |
| Adolescent Migraine Lauren Doyle Strauss, DO, FAHS |
| Peri-Menopause and Menopause Christine Lay, MD, FAHS |
| Injection Training |
| Neurotoxin Therapy and Demonstration Andrew Blumenfeld, MD, FAHS |
| Nerve Blocks and Demonstration Carrie Dougherty, MD, FAHS |
| Basic Science |
| Potential Mechanistic Synergy in Migraine Therapy Rami Burstein, PhD |
| Glymphatics Jeffrey Iliff, PhD |
| Pre-Clinical Models of Headache Greg Dussor, PhD |
| Statistical Issues in Scientific Research Dana Turner, PhD |
| Secondary Headaches – Post-traumatic Headache / CSF Pressure |
| Post-traumatic Headache Management in Pediatric and Adults Juliana VanderPluym, MD, FAHS |
| High CSF Pressure Kathleen B. Digre, MD, FAHS |
| Low CSF Pressure Deborah I. Friedman, MD, FAHS |
| Neuroimaging Linda Gray Leithe, MD |
| Pediatrics |
| Pediatric Use of New Therapies Chaouki K. Khoury, MD, MS, FAHS |
| Headache Hygiene (lifestyle and school) Jessica Gautreaux, MD |
| Migraine Reduction Therapies Meghan S. Candee, MD, MS |
| Challenging Cases Amy Gelfand, MD, FAHS |
| TACs and Other Primary Headaches |
| Other TACs: HC and PH Lawrence C. Newman, MD, FAHS |
| Cranial Neuralgias and SUNCT Rafael Benoliel, BDS (Hons) |
| Other Primary Headaches Matthew S. Robbins, MD, FAHS |
| Case Studies Thomas N. Ward, MD, FAHS Morris Levin, MD, FAHS Amy Gelfand, MD, FAHS |
| Journals and Publications |
| Headache® Thomas N. Ward, MD, FAHS & Amy Gelfand, MD, FAHS |
| Book Review R. Allan Purdy, MD, FAHS |
| Advocacy |
| American Migraine Foundation – Past, Present, Future & Employer/Employee Advocacy Lawrence C. Newman, MD, FAHS & Nim Lalvani, MPH |
| AHDA – Legislative Advocacy Robert E. Shapiro, MD, PhD, FAHS & Katie MacDonald |
| HMPF: Headache & Migraine Policy Lindsay Videnieks, JD |
| AHS: Clinician Advocacy Amaal J. Starling, MD, FAHS |
| Vestibular / Sleep |
| Sleep Didactic Angeliki Vgontzas, MD |
| Basics of Vestibular Migraine Shin C. Beh, MD |
| Demonstration Shin C. Beh, MD |
| Behavioral and Wellness |
| Adult Challenging Cases Steven M. Baskin, PhD |
| Peds Challenging Cases Scott W. Powers, PhD, ABPP, FAHS |
| Mindfulness and Behavioral Apps Mia Minen, MD, MPH, FAHS |
| Demonstration Dawn C. Buse, PhD, FAHS |
| Practice Management |
| Telemedicine Practice Management Tips Brian D. Loftus, MD |
| Updates with CMS Billing and Coding Brad Klein, MD, MBA |
| Case Examples Using Updated CMS Guidance Brian Grosberg, MD, FAHS |
| Headache Lounges |
| Saturday, November 21, 2020 |
| 3:00pm PST
Women in Headache Medicine We have gone virtual this year! Come meet and network with other women members of AHS. Collegial support topic: Personal tips for supporting and promoting women in headache medicine. |
| Sunday, November 22, 2020 |
| 10:00am PST
Weekend Lounge Share your favorite vacation ideas in our current pandemic reality. Feel free to come with your favorite vacation destination Zoom background! Collegial support topic: What are behavioral therapy resources you have found helpful for patients in the digital age? |
| 2:00pm PST
Advanced Course Lounge Discussion surrounding the Advanced Course topic Neuroinflammation and Migraine with faculty. |
| 3:00pm PST
NIT Lounge We have gone virtual this year! Come meet and network with other New Investigators and Trainees. Collegial support topic: Mentoring during the pandemic – share what has worked. |
| 4:00pm PST
Scottsdale Night Let us be nostalgic about Scottsdale and the Southwest! This is the Scottsdale meeting, after all. Share your love of Arizona with your Zoom background, your attire, a Southwest-themed drink, join us form your firepit, or be creative! Collegial support topic: No specific topic of discussion, just come and relax with friends. |
| Wednesday, November 25, 2020 |
| 4:00pm PST
Zen Hour Share how you have been finding ways to experience wellness during this pandemic. Have you read a great book or gotten hooked on a TV series? Your friends want to know! Collegial support topic: Share a favorite telemedicine hack to help with virtual encounters. |
| Sunday, November 29, 2020 |
| 8:00am PST
Breakfast (or Brunch) Lounge Share your favorite easy breakfast ideas! Feel free to bring a cup of coffee or tea to sip as you chat with friends! Collegial support topic: Share what has worked for you to help manage patient expectations. |
| Friday, December 4, 2020 |
| 5:00pm PST
Scottsdale Happy Hour Bring your favorite cocktail or mocktail as you catch up with friends. Collegial support topic: Share tips for patient education strategies during virtual encounters and short visits. |
2020 Virtual Scottsdale Headache Symposium Registration Fees and Information
Online registration is now open. Click here to register.
AHS Member and Non-member Registration Categories and Fees
| Category | Fee |
| AHS MEMBER | Complimentary |
| NON-MEMBER
Trainees, Residents, Medical Students, Graduate Students |
Complimentary |
| NON-MEMBER
Other |
$99.00* |
*This fee may be applied toward an AHS membership after registration has been completed. A discount code will be provided in your registration confirmation email and must be redeemed by January 31, 2021.
Registration Information
Access information to the Virtual Scottsdale Headache Symposium website will be sent to the email address provided during registration prior to the anticipated launch date of November 21, 2020.
Acceptable Forms of Payment
Credit cards may be used for all registrations. AHS accepts Visa, MasterCard, and American Express. Charges will appear on your statement as “AHS Registration.”
Exhibit and Sponsorship Information
The Exhibit and Sponsorship portal will allow you to select a sponsorship opportunity (virtual booth included) or purchase a virtual exhibit booth without sponsorship. You will also be able to upload your logo, booth materials, video chat with meeting attendees and much more.
To access the portal, please click here and create an account (click to start button) for the 2020 Virtual Scottsdale Headache Symposium®.
This year, new, enhanced options for the virtual expo hall are available. These improvements will allow exhibitors and sponsors increased visibility and opportunities to interact virtually with meeting registrants. Listed below are a few of the enhancements** that we hope you find to be beneficial:
- Virtual Booth Banner – will appear at the top of the virtual booth and can link to an external URL
- Introductory Video – a video that provides a short synopsis of your company’s mission or product
- Video Chat Room – sales reps can connect with attendees via video chat from the virtual booth
- Resource Documents – (content links / PDF handouts) – provide attendees with material about your company
**availability of enhancements is based on sponsorship level
Through your account, you will have access to all the up-to-date information regarding the Virtual Scottsdale Headache Symposium. You can also submit payments and manage your account settings through the portal.
Please be prepared to answer a few more questions this year. The Exhibit Review Committee has made some changes to the review process for both previous and new exhibitors. For example, if you have a new product or device, and have exhibited in the past, you may be asked to submit additional collateral before receiving final approval to exhibit.
Please click here to view exhibit and sponsorship opportunities for the 2020 Virtual Scottsdale Headache Symposium.
Industry Supported Events
Industry-supported events, CME or non-CME, will be accessible to all meeting registrants via the virtual meeting site. The deadline to submit requests for Industry-Supported Events has passed.
The American Headache Society gratefully acknowledges the support of the Virtual Scottsdale Headache Symposium from our industry supporters:
Platinum Sponsor
Allergan, an AbbVie company (NYSE: ABBV), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. |
In August 2015, Amgen and Novartis entered into a global collaboration to develop and commercialize pioneering treatments in the field of Neuroscience. At the center of the Amgen and Novartis collaboration is the shared mission to fight migraine and the stereotypes and misperceptions surrounding this debilitating disease. |
Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. |
Teva Pharmaceutical Industries Ltd. has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. |
Gold Sponsor
For more than 70 years, Lundbeck has been at the forefront of brain science. We are committed to providing transformative therapies for brain diseases, and we are tirelessly dedicated to restoring brain health so every person can be their best. |
We at Upsher-Smith Laboratories, LLC are still carrying out our original founder’s commitment to help improve the health and lives of patients. We know that our customers have many options to choose from in the marketplace, but we believe they repeatedly choose us because we go above and beyond – striving for uninterrupted supply, quick delivery and in-depth account and patient knowledge. |
Silver Sponsor
 |
Bronze Sponsor
 |
 |
AHS gratefully acknowledges the educational support of the Virtual Scottsdale Headache Symposium from our industry supporters:
Allergan, an AbbVie company (NYSE: ABBV)
Amgen, Inc.
AHS gratefully acknowledges the educational support of the Anatomy of Headache and Orofacial Pain: An Interventional Based Cadaver Course from our industry supporters:
Allergan, an AbbVie company (NYSE: ABBV)
“Frontiers in Headache Research” Award
AHS announces the availability of the “Frontiers in Headache Research” Awards for the opportunity to present virtually during the 2020 Virtual Scottsdale Headache Symposium.
Winners will receive complimentary meeting registration and a one-year AHS Trainee membership if not already a member of AHS, or a one-year extension of their existing AHS Trainee membership.
Criteria for selection are based on:
- The quality of the research proposal/project
- The potential for the proposal, study or thesis to contribute to the advancement of knowledge and future research in the field of headache medicine
Applicant must:
- Be a headache medicine Fellow, Resident, and/or post-doctoral Fellow who is in preparatory, active or completion phase of a basic or clinical research project that is related to headache or cranial nociception
- Not have won an AHS scholarship within the past 2 years
- Reside in the United States or Canada
Recipient requirements:
- The top three selected will be required to submit a virtual platform presentation during the 2020 Virtual Scottsdale Headache Symposium
- All other recipients will be required to submit a virtual poster for display during the 2020 Virtual Scottsdale Headache Symposium
Thank you for your interest in the “Frontiers in Headache Research” Award. The application period has passed.
Women’s Health Science Award
The American Headache Society’s Women’s Health Science Award recognizes an investigator, woman or man, whose body of work has made an outstanding contribution to the understanding of topics related to women’s health (sex or gender) and headache medicine. Investigators whose original research has pertained to basic science, clinical or multidisciplinary research may be considered for this award.
This award makes a statement that women’s issues in headache medicine are of crucial importance and that enduring work in such an area should be recognized and rewarded. The award will be presented during the 2020 Virtual Scottsdale Headache Symposium.
The award recipient will receive the following:
- Complimentary registration and the opportunity to present their award-winning body of work during the 2020 Virtual Scottsdale Headache Symposium
- The invitation to write a review article in Headache® on their award-winning topic
- A certificate of recognition
Thank you for your nomination! The nomination period has passed.
AHS members are invited to participate in Special Interest Section meetings that will be held virtually via Zoom. To access dial-in details, please log into your member account and access the event under “My Profile.”
| Date | Time (ET) | Section |
| 2-Nov | 7:00 – 8:00 pm | Primary Front Line Headache Care |
| 5-Nov | 7:00 – 8:00 pm | Underserved Populations in Headache Medicine |
| 9-Nov | 7:00 – 8:00 pm | CSF Pressure and Volume Disorders |
| 10-Nov | 7:00 – 8:00 pm | Complementary and Integrative Medicine |
| 11-Nov | 7:00 – 8:00 pm | Advanced Practice Providers |
| 13-Nov | 3:00 – 4:00 pm | Post-traumatic Headache |
| 13-Nov | 7:00 – 8:00 pm | Refractory, Inpatient, and Emergency Care |
| 17-Nov | 12:00 – 1:00 pm | Women’s Health |
| 17-Nov | 8:00 – 9:00 pm | Pediatric-Adolescent Headache |
| 18-Nov | 6:00 – 7:00 pm | TMD, Cervical Spine, & Orofacial Pain |
| 18-Nov | 7:00 – 8:00 pm | Behavioral Issues |
| 19-Nov | 6:00 – 7:00 pm | Procedural Headache Medicine |
| 19-Nov | 7:00 – 8:00 pm | Methodology, Design, and Statistical Issues |
| 19-Nov | 8:00 – 9:00 pm | New Investigators and Trainees |
| 24-Nov | 7:00 – 8:00 pm | Trigeminal Autonomic Cephalalgias |
| 23-Nov | 7:00 – 8:00 pm | Clinical Informatics |
| 25-Nov | 6:00 – 7:00 pm | Migraine and Vascular Disease |